<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="nlm-table-wrap-1" xml:lang="en" orientation="portrait" position="anchor">
 <table frame="hsides" rules="groups">
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <tbody valign="top">
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Thursday 19 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.55‐16.10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Belachsen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Acute effect of oral pimobendan on left atrial function and mitral valve regurgitation severity in dogs with stage B2 myxomatous mitral valve disease – A pilot study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.10‐16.25</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ward</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Retrospective evaluation of the safety and tolerability of pimobendan in cats with obstructive versus nonobstructive hypertrophic cardiomyopathy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.25‐16.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Crosara</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Aorto‐septal angle, isolated basal septal hypertrophy and systolic murmur in 122 cats</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Friday 20 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.20‐11.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Menciotti</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Accuracy of noninvasively determined pulmonary artery pressure in dogs with myxomatous mitral valve disease (MMVD)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.35‐11.50</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ksiazek</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Left atrial tear in dogs with myxomatous mitral valve disease ‐ clinical presentation, echocardiographic features and long‐term survival</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.50‐12.05</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Claretti</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Echocardiographic evaluation of left ventricular dimension and systolic function before and 24 hours after percutaneous closure of patent ductus arteriosus in 120 dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.05‐12.20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Adin</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Delayed Electrolyte Depletion and Azotemia in a Furosemide Rate Continuous Infusion Model</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.20‐12.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Culshaw</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Changes in renal endothelin activity with cardiac, renal and other chronic diseases in dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.35‐12.50</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Spalla</td>
    <td align="left" valign="top" rowspan="1" colspan="1">High grade AV Block and third degree AV Block in cats: a retrospective study of epicardial pacemaker implantation (2006‐2018) focusing on signalment, presentation and survival</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.25‐14.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">van Hoek</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Diet‐induced reduction of cardiac wall thickness, Troponin‐I and IGF‐1 in cats with asymptomatic hypertrophic cardiomyopathy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.40‐14.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Patata</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Biomarker discovery in cats with cardiomyopathy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.55‐15.10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hanås</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Blood pressure measurement by High Definition Oscillometry in different clinical settings in healthy cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.10‐15.25</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐13</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Busato</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Does pleural effusion protect against arterial thromboembolism in feline congestive heart failure?</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.25‐15.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐14</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ferasin</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Iatrogenic heart murmur: a new cause of systolic murmurs in cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.40‐15.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Giraud</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Point Of Care Ultrasound of the Caudal Vena Cava in Canine Degenerative Mitral Valve Disease.</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.30‐16.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐16</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bourguignon</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Echocardiographically determined left ventricular volume indices obtained from two views in dogs show good agreement</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.45‐17.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐17</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Greet</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Supraventricular tachycardia in 23 cats; comparison with 21 cats with atrial fibrillation (2004‐2014)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.00‐17.15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐18</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Perego</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Electrocardiographic patterns of ventricular pre‐excitation in the dog</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.15‐17.30</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐19</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Perego</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Use of the cutting balloon technique for the treatment of subvalvular pulmonary stenosis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.30‐17.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Costa</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Imaging and clinical features of canine right atrial appendage aneurysm: a single‐centre cross‐sectional study in 10886 dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.45‐18.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐O‐21</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Franchini</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Predictors of reoccurrence of congestive signs in dogs with ACVIM‐Stage C myxomatous mitral valve disease (MMVD)</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>SCH – Society of Comparative Hepatology</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Thursday 19 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">09.45‐10.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">SCH‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ferreira</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lactulose drives a reversible reduction and qualitative modulation of the faecal microbiota diversity in healthy dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">10.00‐10.15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">SCH‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Verwey</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prevalence of bactibilia in apparently healthy dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">10.15‐10.30</td>
    <td align="left" valign="top" rowspan="1" colspan="1">SCH‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Devriendt</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hyaluronic acid as a liver function test to asses extrahepatic portosystemic shunt closure in dogs after surgical attenuation</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>ESVCP – European Society of Veterinary Clinical Pathology</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Thursday 19 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.05‐12.20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Škor</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Plasma lactate dehydrogenase as a prognostic marker for nodal diffuse large B‐cell lymphoma in dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.20‐12.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prasinou</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The paradigm of erythrocyte membrane lipidome in healthy dogs: first evaluation of the optimal interval values of a fatty acid cluster</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.35‐12.50</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Zoia</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Grade of severity, type of fibrinolysis and degree of agreement between rotational thromboelastometry (ROTEM) and FDPs, D‐dimer and fibrinogen concentrations: a case‐ control study of 64 dogs with or without abdominal and/or pleural effusions</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.25‐14.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Zoia</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Rotational thromboelastometry (ROTEM) fibrinolytic activity in dogs with abdominal and/or pleural effusions: a case control study in 64 dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.40‐14.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Johnsen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Investigation of the relationship between ionised and total calcium in dogs with ionised hypercalcaemia</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.55‐15.10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Dewhurst</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The effect of boric acid on bacterial culture of non‐cystocentesis canine and feline urine samples</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.10‐15.25</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cervone</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prospective evaluation of inter‐ and intra‐observer agreement for standard visual dipstick urinalysis in dogs and cats and comparison with an automated method</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.25‐15.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bennaim</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Dilution and storage effects on free T4 concentrations measured by equilibrium dialysis or analogue immunoassay</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.40‐15.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Vizi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Detection of canine serum hepcidin with LC/MS method in healthy dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.55‐16.10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐O‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Guzmán Ramos</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of hypocholesterolaemia in dogs</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>ESVNU – European Society of Veterinary Nephrology and Urology</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Thursday 19 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.25‐14.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Amram</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Serum symmetric dimethylarginine in dogs and cats with acute kidney injury treated with intermittent hemofiltration</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.40‐14.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Faucher</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Non‐obstructive “acute on chronic” kidney disease in the cat: is it possible to predict survival?</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.55‐15.10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ferreira</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effect of measurement location on systolic blood pressure (SBP) readings in out‐patient and in‐patient dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.10‐15.25</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Rossi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Immune‐complex glomerulonephritis in cats: a retrospective study based on clinico‐pathological data and morphological features</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.25‐15.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Mantelli</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Short course of immune‐suppressive doses of prednisolone is associated with renal hyperfiltration and changes in hydration and electrolyte status in healthy beagle dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.40‐15.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Snell</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Characterization and in vitro susceptibility of clinical feline UPEC isolates to an E. coli probiotic as a potential therapeutic for urinary tract infection</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.55‐16.10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Baumgartner</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prognostic factors in dogs with common causes of proteinuria</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.10‐16.25</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bijsmans</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The effect of dietary sodium on urinary calcium and calcium oxalate relative supersaturation (CaOx RSS) in dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.25‐16.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐O‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Caccamo</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Proliferative urethritis in dogs: long‐term follow up and prognosis</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>ISCAID ‐ International Society for Companion Animal Infectious Diseases</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Thursday 19 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.20‐11.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Carrai</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Detection of canine and feline parvovirus shedding in asymptomatic shelter cats in Australia using a minor groove binder probe real‐time PCR assay</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.35‐11.50</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Petini</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prognostic value of systemic inflammatory response syndrome (SIRS) presence, serum acute phase proteins, cholesterol and total thyroxine concentrations in cats with feline panleukopenia: a retrospective cohort study in 70 cats (2010‐2018)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.50‐12.05</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bordicchia</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Clinical and epidemiological features of the first reported outbreaks of feline calicivirus virulent systemic disease in Australia and in vitro efficacy of three antiviral compounds: nitazoxanide, 2’‐C‐methylcytidine and NITD‐008</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.05‐12.20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bergmann</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Antibody response to feline calicivirus vaccination in healthy adult cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.20‐12.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Felten</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Correlation of feline coronavirus shedding in faeces with serum coronavirus antibody titre</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.35‐12.50</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Dandrieux</td>
    <td align="left" valign="top" rowspan="1" colspan="1">A retrospective multi‐centre study on treatment and outcome in disseminated aspergillosis in 41 dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.25‐14.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cervone</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Canine Trichuris vulpis infection: a retrospective study of 45 cases</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.40‐14.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lutz</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Patterns of antimicrobial use for selected canine diseases in Switzerland in 2016</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.55‐15.10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hubbuch</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Comparison of antimicrobial prescription in selected diseases in cats in Switzerland between 2016 and 2018: a trend towards more prudent antimicrobial use</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.10‐15.25</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Schmidt</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of hand hygiene compliance in small animal clinics and practices in Switzerland using the CleanHands application</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.25‐15.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Schmidt</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of infection prevention and control standards and carriage of multidrug‐resistant organisms in working staff in small animal clinics and practices in Switzerland</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.40‐15.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐O‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Schuller</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prevalence, acquisition and persistence of rectal and naso‐/oropharyngeal carriage of multidrug‐resistant organisms in dogs and cats presented to veterinary practices and their owners</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>ESCG – European Society of Comparative Gastroenterology</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Friday 20 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">09.45‐10.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ruggerone</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The fecal microbiota and unconjugated fecal bile acids in dogs with diabetes mellitus</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">10.00‐10.15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Stavroulaki</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Impact of antibiotic administration on fecal bacterial groups potentially associated with dysbiosis in kittens</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">10.15‐10.30</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bermudez Sanchez</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Fecal microbial metabolism is altered in dogs with chronic enteropathy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.20‐11.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐O‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Swales</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The pug breed demonstrates a worse response to treatment of protein‐losing enteropathy than other breeds of dog</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.35‐11.50</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐O‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Petrelli</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Is measuring serum folate pointless? Retrospective analysis of prevalence and clinical significance of hypo‐ or hyperfolataemia in dogs with chronic enteropathies</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.50‐12.05</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐O‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Moberg</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Dogs with acute haemorrhagic diarrhoea syndrome not receiving antibiotics have a good prognosis despite initial high AHDS‐score and systemic inflammation</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.05‐12.20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐O‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ziese</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Faecal bile acid profiles in dogs with acute haemorrhagic diarrhoea syndrome over time and compared to healthy dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.20‐12.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐O‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Kaufmann</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Long‐term consequences of acute hemorrhagic diarrhea syndrome in dogs</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>ESVIM – European Society of Veterinary Internal Medicine</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Friday 20 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.30‐16.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hirt</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pulmonary deposition of nebulized 99mTc‐DTPA after pharmacologically induced airway narrowing in healthy dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.45‐17.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Fastrès</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Assessment of lung microbiota in healthy dogs: impact of breed and living conditions</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.00‐17.15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Grobman</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Protein biomarkers in regurgitation, vomiting, and cough: proteomic characterization of canine gastric fluid by liquid chromatography mass spectrometry (LCMS)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.15‐17.30</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Jaffey</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Serum 25‐hydroxyvitamin D in dogs with sinonasal aspergillosis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.30‐17.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Jaffey</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Plasma mRNA cathelicidin expression in hospitalized critically ill dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.45‐18.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Jaffey</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hereditary methemoglobinemia in dogs caused by cytochrome b5 reductase deficiency associated with variants in CYB5R3</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Saturday 21 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.30‐16.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Jones</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Differences in clinical presentation of common dog breeds diagnosed with primary IMHA</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.45‐17.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">de Laet</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Diagnostic imaging findings in a referral population of dogs diagnosed with immune‐mediated haemolytic anaemia</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.00‐17.15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ebelt</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Determination of Blood Groups DEA 1, DEA 4, DEA 5, Dal, and Kai 1/2 in Different Canine Breeds</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.15‐17.30</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ferri</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Systemic AA‐amyloidosis in shelter cats and shedding of amyloid fibrils</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.30‐17.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐O‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Rabozzi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Treatment of non‐lactate metabolic acidosis in hypovolemic and normovolemic dogs: chloride‐free iso‐osmolar solution with elevated Strong Ion Difference versus Ringer’s Lactate solution</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>ESVONC – European Society of Veterinary Oncology</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Friday 20 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.25‐14.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Aupperle‐Lellbach</td>
    <td align="left" valign="top" rowspan="1" colspan="1">BRAF‐mutation in carcinomas of various sites in the canine urinary tract</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.40‐14.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Kleiter</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Re‐irradiation is a valuable treatment option for dogs and cats with cancer after failing first line therapy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.55‐15.10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Borgatti</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Impact of Repeated Cycles of EGF Bispecific Angiotoxin (eBAT) Administered at a Reduced Interval from Doxorubicin Chemotherapy on Tolerability and Survival of Dogs with Splenic Hemangiosarcoma</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.10‐15.25</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Škor</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Humoral hypercalcemia of malignancy in canine lymphoma WHO types and its impact on survival</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.25‐15.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Rigas</td>
    <td align="left" valign="top" rowspan="1" colspan="1">High risk mast cell tumours with favourable outcome in 16 young dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">15.40‐15.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Willcox</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Diphenhydramine Does Not Reduce Infusion‐Related Ventricular Arrhythmias in Dogs Treated with Doxorubicin</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.30‐16.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Škor</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Time to change from WHO staging to Ann‐Arbor system in canine nodal diffuse large B‐cell lymphoma?</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">16.45‐17.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Willcox</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Accuracy of PET for Detection of Lymph Node Metastasis in Canine Oral Malignant Melanoma</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.00‐17.15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Fournier</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Efficacy of diosmectite in the management of chemotherapy‐induced diarrhoea in dogs: an open‐label randomised clinical trial</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.15‐17.30</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Fournier</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Contrast‐enhanced ultrasound for sentinel lymph node identification in the routine staging of canine mast cell tumours: a feasibility study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.30‐17.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ossowska</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Dorsal rhinotomy in 18 dogs with intranasal tumors</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">17.45‐18.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐O‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Wood</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The Use of Low‐dose Radiation Therapy for the Treatment of Small &amp; Intermediate Cell Gastrointestinal Lymphoma in Cats</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>ESVE – European Society of Veterinary Endocrinology</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Saturday 21 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">09.00‐09.15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Mack</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The Relationship of SDMA and Creatinine in Cats with Subnormal Total T4 After Hyperthyroidism Treatment</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">09.15‐09.30</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Kelly</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prevalence of ‘Atypical’ Addison’s disease among a population of dogs diagnosed with hypoadrenocorticism</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">09.30‐09.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Petini</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The predictive role of the transtubular potassium gradient (TTKG) for Addison syndrome in hyperkaliemic dogs: a cross‐sectional study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">09.45‐10.00</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Golinelli</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Comparison of different monitoring methods in dogs with hypercortisolism treated with trilostane</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">10.00‐10.15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tardo</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Feline plasma adrenocorticotropic hormone: validation of a chemiluminescent assay and concentrations in cats with hypercortisolism, primary hypoadrenocorticism and other diseases</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">10.15‐10.30</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Denyer</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Major Histocompatibility Complex (MHC) class II haplotypes associated with increased risk of canine diabetes mellitus – a breed‐specific study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">10.30‐10.45</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Copley</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Comparison of nine canine serum thyroxine measurement methods and impact of T4 cross‐reacting autoantibodies</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.20‐11.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hazuchova</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Analysis of GWAS data in Domestic Shorthair and Burmese cats identifies diabetes‐associated loci near the DPP9 and within the DPP10 gene</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.35‐11.50</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Kraemer</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Glycemic variability in newly diagnosed diabetic cats treated with the GLP‐1 analogue exenatide extended‐release</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">11.50‐12.05</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">del Baldo</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Clinical perfrormances of flash glucose monitoring system in diabetic dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.05‐12.20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Davison</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Whole Genome Sequencing to explore genetic risk factors in canine diabetes mellitus</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.20‐12.35</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Linari</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of 1,2‐o‐dilauryl‐rac‐glycero glutaric acid ‐ (6’‐methylresorufin) ester (DGGR) lipase assay in dogs with naturally occurring hypercortisolism</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.35‐12.50</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐13</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bennaim</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Comparison of measurement of free thyroxine concentration by a chemiluminescent analogue immunoassay to equilibrium dialysis in dogs with non‐thyroidal illness</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">12.50‐13.05</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐O‐14</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tièche</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Organoid cultures of follicular‐cell thyroid carcinoma: a novel canine model for translational thyroid cancer research</td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">
     <bold>ESVCN – European Society of Veterinary Comparative Nutrition</bold>
    </td>
   </tr>
   <tr>
    <td colspan="4" align="left" valign="top" rowspan="1">Saturday 21 September</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.25‐14.40</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCN‐O‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Jeusette</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Dietary lemon balm and fish peptides enhance the efficacy of L‐tryptophan to reduce urinary cortisol, a stress marker in cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">14.40‐14.55</td>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCN‐O‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Nybroe</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Metabolic effects of a diet with Enterococcus faecium NCIMB 10415 for healthy adult dogs</td>
   </tr>
  </tbody>
 </table>
 <table frame="hsides" rules="groups">
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <col align="left" span="1"/>
  <tbody valign="top">
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>LIST OF POSTER RESEARCH COMMUNICATIONS</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
    <td align="left" valign="top" rowspan="1" colspan="1"/>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ESVC – European Society of Veterinary Cardiology</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Baisan</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Heart rate variability of dogs in various stages of degenerative mitral valve disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">van Israel</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Comparison of serum digoxin concentrations from blood collected in Vacutainer® tubes with or without gel</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Caivano</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Transverse right ventricle strain and strain rate assessed by 2‐dimensional speckle tracking echocardiography in dogs with pulmonary hypertension</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lee</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Potential renoprotective effect of angiotensin‐receptor antagonists in dogs with myxomatous mitral valve disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Takamura</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Perioperative management with peripheral arteries in dogs undergoing open heart surgery</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Martinelli</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effects of in‐hospital diuretic therapy on electrolytes concentration, renal function and survival in 85 dogs with acute congestive heart failure</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Yilmaz</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Platelet proteomic profile in dogs with heart failure</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ware</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Vitamin D Status in Cats with Cardiomyopathy compared to Normal Cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cheng</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Identification of increased desmin aggregates consistent with intermediate filament dysfunction in feline hypertrophic cardiomyopathy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Guglielmini</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prevalence and risk factors for atrial fibrillation in dogs with myxomatous mitral valve disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Poissonnier</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Left atrial volume assessment in 160 Cavalier King Charles Spaniels with and without degenerative mitral valve disease (2017‐2019)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Passavin</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hematological abnormalities in dogs with congenital arterial stenosis: a prospective study of 56 cases (2017‐2019)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐13</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Poissonnier</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Use of torasemide in cats with congestive heart failure: 17 cases (2016‐2019)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐14</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Guarnera</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Use of torasemide as a second line diuretic in dogs with congestive heart failure</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Mazzoldi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Echocardiographic predictors of first onset of atrial fibrillation in dogs with myxomatous mitral valve disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐16</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Romito</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Usefulness of Holter‐derived Lorenz plots analysis to discriminate different cardiac rhythms in dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐17</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Adin</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Visual Representations of Cardiac Arrhythmias in Dogs using Lorenz Plots</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐18</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Borenstein</td>
    <td align="left" valign="top" rowspan="1" colspan="1">First case of successful transcatheter pulmonary valve implantation in a dog with severe pulmonary regurgitation</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐19</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Claretti</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Normal aortic annulus dimensions in Boxer dogs according to sex and body weight</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Domanjko Petric</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Inflammatory and oxidative stress markers are associated with survival in canine cardiovascular patients</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐21</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Domanjko Petric</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Right heart remodelling in brachycephalic obstructive airway syndrome</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐22</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Baron Toaldo</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effect of a single dose of Pimobendan on right ventricular and atrial function in healthy cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐23</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Harjen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ambulatory electrocardiography and serial cardiac specific troponin I measurement in twenty‐two dogs envenomated by the European Adder (Vipera berus)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐24</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Parmentola</td>
    <td align="left" valign="top" rowspan="1" colspan="1">E point to septal separation (EPSS): difference of measurement from the right parasternal long axis and short axis view in dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐25</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Takahashi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Investigation report of the effect of long flightprolonged air travel on dogs with heart mitral valve disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVC‐P‐26</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lekane</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Clinical, ECG and echocardiographic findings in a canine case series of presumptive myocardial infarction</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>SCH – Society of Comparative Hepatology</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">SCH‐P‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Borusewicz</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The use of MRI and gadoxetic acid to differentiate hepatic parenchymal hyperplastic lesions in dogs</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ESVCP – European Society of Veterinary Clinical Pathology</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Martín</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Serological and molecular detection of Leishmania infantum in stray cats in an endemic region of Spain</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Franco‐Martínez</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Serum and salivary adiponectin dynamics in dogs before and after ovariohysterectomy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Baxarias</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effect of storage on nitroblue tetrazolium reduction test in dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Kocaturk</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Identification of serum proteins in dogs naturally infected with Anaplasma phagocytophilum and Borrelia burgdorferi</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tulone</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hypergammaglobulinemia as a marker of hepato‐pancreatic involvement in enteropathic cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Gori</td>
    <td align="left" valign="top" rowspan="1" colspan="1">C‐Reactive Protein/Albumin ratio in canine acute pancreatitis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Navarro Martínez</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Urine capillary electrophoresis reference intervals for healthy dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cantos Barreda</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Does the time at sampling influence the measurement of anti‐Leishmania antibodies in serum and saliva of dogs with clinical leishmaniosis?</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pierini</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Platelet abnormalities and platelet‐to‐lymphocyte ratio (PLR) in canine immunosuppressant‐responsive enteropathy (IRE): a retrospective study on 41 patients</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCP‐P‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Galizzi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The urine aldosterone to creatinine ratio (UAldo:C) determined by enzyme‐linked immunosorbent assay (ELISA) in healthy dogs and dogs with myxomatous mitral valve disease</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ESVNU – European Society of Veterinary Nephrology and Urology</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Breu</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Uroliths in dogs from Europe and China ‐ a comparative study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Fidalgo</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Significant Feline Proteinuria: a retrospective study of its aetiology in 61 cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Paz</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The role of vector‐borne diseases in the aetiology of overt canine proteinuria: a retrospective study in 106 dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Falus</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of the diagnostic value of urinary albumin to protein ratio in proteinuric dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Neagu</td>
    <td align="left" valign="top" rowspan="1" colspan="1">N‐acetil‐ß‐D‐glucozaminidase index as an early renal tubular damage marker in male cats with obstructive lower urinary tract disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pagnamenta</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Non‐symptomatic bacteriuria is common in young female boxer dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Gori</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of symmetric dimethylarginine (SDMA) in canine acute pancreatitis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">From</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of a point‐of‐care lateral flow immunoassay for detection of significant bacteriuria in dogs and cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Perondi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Antioxidant enzyme activity in dogs with acute uraemia managed with haemodialysis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pantaleo</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Risk factors for urinary tract infection in dogs with natural occurring leptospirosis: a retrospective cohort study of 76 dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Manczur</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Accuracy of refractometric urine specific gravity determination in cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Duque</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Early detection of tubular damage in dogs infected with Leishmania infantum: use of N‐acetyl‐ß‐D‐glucosaminidase (NAG) and glutamyl transferase (GGT)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐13</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Duque</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Usefulness of urine neutrophil gelatinase–associated lipocalin (NGAL) and Cystatin C (CysC) in the diagnosis of renal disease in dogs affected with leishmaniasis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐14</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Zambarbieri</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Complicated UTI in dogs: uropathogens, antimicrobial resistance and comorbidity</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVNU‐P‐15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Scarpa</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cats at risk or with spontaneous CKD. What affects survival and prognosis?</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ISCAID – International Society for Companion Animal Infectious Diseases</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Carnés</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Circulating immune complexes levels correlate with the progression of canine leishmaniosis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cabré</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Clinicopathological findings in canine leishmaniosis and its association with signalment</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Su</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Correlation between the molecular epidemiology of canine Babesia species and the distribution of vector ticks on dogs in Taiwan</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Liu</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Risk factors of Babesia gibsoni infection from client‐owned dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pacifico</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Acantocheilonema reconditum in hunting dogs from Southern Italy: distribution, risk factors and haemato‐biochemical findings</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Sarpataki</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effect of human antiretroviral compound Tenofovir in the treatment of cats naturally infected with feline immunodeficiency virus (FiV)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Gatellet</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The many faces of Lyme borreliosis in dogs: a review of 29 suspected clinical cases</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Piantedosi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Distribution and risk factors of canine hemotropic mycoplasmas in hunting dogs from Southern Italy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Palerme</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prevalence of vector‐borne diseases in free‐roaming cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Walker</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Retrospective analysis of cases tested for leptospirosis at a university teaching hospital</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ISCAID‐P‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Guzmán Ramos</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Canine urine culture and antimicrobial susceptibility patterns over an eight‐year period: increasing antimicrobial and multidrug resistance</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ESCG – European Society of Comparative Gastroenterology</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Benvenuti</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Foxp3 and histopathological lesions in relation to outcomes in canine immunosuppressant‐responsive enteropathy (Ire): prospective analysis in 57 dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tabar</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prevalence and significance of increased TLI concentrations in clinical practice</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lyngby</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Serum 25‐hydroxyvitamin D3 in dogs with acute gastrointestinal diseases</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Gori</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of abdominal ultrasound features in relation with canine Spec cPL, the severity of disease and mortality in suspected canine acute pancreatitis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Candido</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Gastric mucosal pathology in Belgian Shepherd dogs with and without clinical signs of gastric disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cristóbal Verdejo</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effect of stem cell therapy on serum cobalamin levels in dogs diagnosed with chronic enteritis without cobalamin supplementation</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Becher</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Neutrophil‐to‐lymphocyte ratio (NLR) as a biomarker in dogs with chronic inflammatory enteropathies</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hanifeh</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Calprotectin concentrations are increased in the intestinal mucosa of dogs with chronic inflammatory enteropathies</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Benvenuti</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Neutrophil‐to‐lymphocyte ratio (NLR) in canine patients with immunosuppressant‐responsive enteropathy (IRE)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ambrosini</td>
    <td align="left" valign="top" rowspan="1" colspan="1">A Novel Canine‐Specific Model System to Study Intestinal P‐Glycoprotein‐Mediated Drug Transport</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Johnsen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Investigation of the efficacy of a novel diet in the management of chronic enteropathies in dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Jergens</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effect of dietary fat content on mucosal microbiota and serum metabolome in healthy beagles</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐13</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Crisi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">The erythrocyte membrane lipidome in dogs with chronic enteropathy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐14</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Da Riz</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hypercobalaminaemia and its possible association with disease severity in dogs: a retrospective study of 47 cases</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pignataro</td>
    <td align="left" valign="top" rowspan="1" colspan="1">In vitro model (SCIME) to study the intestinal microbiota in dog</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐16</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hernandez</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Expression and distribution of Toll‐Like Receptor (TLR)2, TLR4, TLR5 and TLR9 in the colonic mucosa of dogs with Inflammatory Bowel Disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐17</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Weiß</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Serum Vitamin A and E concentrations in dogs with pancreatitis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESCG‐P‐18</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Galiazzo</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Water immersion vs gas insufflation in canine duodenal endoscopy: is the future underwater?</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ESVIM – European Society of Veterinary Internal Medicine</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bottero</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Retrospective study of 23 cases of canine nasal polyposis, of which 10 were treated endoscopically</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Keiner</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Diagnostic utility of reticulocyte haemoglobin content (RETIC‐HGB) to detect iron‐limited erythropoiesis in cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Slawuta</td>
    <td align="left" valign="top" rowspan="1" colspan="1">A comparison of the diagnostic utility of the classic model, the value of the Anion Gap (AG), corrected Anion Gap (AGcorr) and the chloride/sodium ratio in the diagnosis of acid‐base basalnce disturbances in cats with chronic kidney disease (CKD)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Schulz</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of different cleaning methods for bacterial decontamination of feline aerosol chambers</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lubas</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of clinico‐pathological alterations including some leukocyte ratios and survival rate in dogs with IMHA transfused and not transfused: a retrospective study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">di Loria</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Expression of serum exosomal miRNA 122 in dogs naturally infected by Leishmania infantum</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Tulone</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Anemia and hypoferremia in cats with hepato‐pancreatic and intestinal involvement</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lam</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lung ultrasound findings in dogs using a regionally based protocol (Vet BLUE) versus entire thorax scanning</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Drut</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Comparison of plasma metabolomic profiles of healthy adult cats with low or high plasma homocysteine concentration</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Gianesini</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Association between immune‐mediated hemolytic anemia (IMHA) and acute pancreatitis in dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐13</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Easley</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of Serum Procalcitonin in Dogs with Induced Endotoxemia as a Biomarker for Sepsis</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐14</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Cortese</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effect of a weight loss program on metabolic and immunological profile, blood leptin level and cardiovascular parameters in obese dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐15</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Beaujard</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Life expectancy and causes of mortality of dogs at the National Veterinary School of Toulouse between September 2007 and September 2017 : retrospective study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐16</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Aromaa</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Comparison of habitual physical activity levels in French Bulldogs and normocephalic dogs – a pilot study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐17</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Canonne‐Guibert</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Normal or mild increased C‐reactive protein values in 16 dogs with bronchial and pulmonary infection with Bordetella bronchiseptica</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐18</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Viitanen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Polycythemia is uncommon in dogs with chronic hypoxic pulmonary disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐19</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Greci</td>
    <td align="left" valign="top" rowspan="1" colspan="1">A statistical analysis to predict persistence of canine sinonasal aspergillosis at endoscopic follow‐up by comparing three different scoring systems: a retrospective study of 47 cases treated with one hour 1% clotrimazole per‐endoscopic infusion and undergoing endoscopic follow‐up</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐20</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Spada</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluation of feline packed red blood cell units obtained by blood sedimentation and stored for 42 days for transfusion purposes</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐21</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Flageollet</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bronchoscopic findings in dogs with bronchial vegetal foreign bodies : a retrospective study of 52 cases (2010‐2019)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐22</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Vangrinsven</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Assessment of nasal microbiota in healthy dogs of different breeds</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVIM‐P‐23</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Peano</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Canine sino‐nasal aspergillosis in Italy (38 cases)</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ESVONC – European Society of Veterinary Oncology</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐P‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Bottero</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Multicentric and prospective study on 271 cases of endonasal neoformations in the dog</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐P‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Thumser‐Henner</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Sensitivity of canine and human cancer cell lines towards thermoradiotherapy</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐P‐3</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Lanore</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Interest of the association of abdominal ultrasound and alanine transaminase (ALT) measurements in the determination of hepatic infiltration in case of nodal diffuse large B‐cell lymphoma (DLBLCL)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐P‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Campigli</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pet owner feedback on psychological support service in an Italian veterinary hospital: a survey data</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVONC‐P‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Mosca</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Evaluating the myelosupressive effects of a single dose of vincristine in dogs with lymphoma</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ESVE – European Society of Veterinary Endocrinology</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Codea</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Hypothyroidism and its association with extra hepatic biliary diseases in dogs: a retrospective case‐control study</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐2</td>
    <td align="left" valign="top" rowspan="1" colspan="1">van den Berg</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Planar and SPECT imaging of canine thyroid tumors: 68 cases</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐4</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pérez‐López</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ultrasonographic evaluation of adrenal gland thickness in healthy dogs and in dogs with hyperadrenocorticism</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐5</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ledda</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Ultrasonographic accuracy in primary adrenal insufficiency: a retrospective cohort study of 182 dogs</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐6</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Graham</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effect of sample dilution on free T4 depends on physiological state and analytical method</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐7</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Canonne‐Guibert</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Survival in cats with diabetes mellitus and chronic pancreatitis: a preliminary study of 36 cases</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐8</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Niessen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Efficacy of once daily Protamine Zinc Recombinant Human Insulin (ProZinc®) in canine diabetes mellitus</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐9</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Garcia</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Brachycephalic morphotype and pituitary tumor size in dogs with Cushing’s disease</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐10</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Pierini</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Critical illness‐related corticosteroid insufficiency (CIRCI) in dogs with systemic inflammatory response syndrome (SIRS)</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐11</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Nerhagen</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Prednisolone induced hyperglycaemia and diabetes mellitus in cats</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐12</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Malerba</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Accuracy and precision of insulin administration using human and veterinary pen‐injectors and syringes</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐13</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Carotenuto</td>
    <td align="left" valign="top" rowspan="1" colspan="1">fractional excretion of electrolytes in dogs with primary hypoadrenocorticism before and after treatment</td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVE‐P‐14</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Kiss</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Effects of bodyweight, age and pituitary hyperadrenocorticism on the adrenal gland size of dogs, measured by ultrasonography</td>
   </tr>
   <tr>
    <td colspan="3" align="left" valign="top" rowspan="1">
     <bold>ESVCN – European Society of Veterinary Comparative Nutrition</bold>
    </td>
   </tr>
   <tr>
    <td align="left" valign="top" rowspan="1" colspan="1">ESVCN‐P‐1</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Koizumi</td>
    <td align="left" valign="top" rowspan="1" colspan="1">Studies on estimation of ideal body weight by morphometry in dogs</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
